Iron metabolism and mitochondrial abnormalities in Friedreich ataxia

被引:50
作者
Pandolfo, M [1 ]
机构
[1] Free Univ Brussels, Hop Erasme, Serv Neurol, B-1070 Brussels, Belgium
关键词
D O I
10.1006/bcmd.2002.0591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Friedreich ataxia is an autosomal recessive disease causing degeneration in the central and peripheral nervous system, cardiomyopathy, skeletal abnormalities and increased risk of diabetes. It is caused by deficiency of frataxin, a highly conserved nuclear-encoded mitochondrial protein. The genetic mutation found in 98% of Friedreich ataxia chromosomes is the unstable hyperexpansion of a GAA triplet repeat in the first intron of the gene. The expanded GAA repeat, by adopting an abnormal triple helical structure, impairs frataxin transcription. Longer repeats cause a more profound frataxin deficiency and are associated with earlier onset and increased severity of the disease. Yeast cells deficient in the frataxin homologue (Deltayfh1) become unable to carry out oxidative phosphorylation, lose mitochondrial DNA, accumulate iron in mitochondria, show unregulated high expression of high affinity iron uptake, and have an increased sensitivity to oxidative stress. Loss of respiratory competence in Deltayfh1 is iron-dependent. Additional properties of these cells include a deficiency of iron-sulfur cluster containing proteins (ISPs) and impaired iron efflux out of mitochondria. Evidence of oxidative stress, mitochondrial dysfunction, deficiency of multiple ISPs and iron deposits are also found in the human disease and in mouse models. The primary function of frataxin is still unknown, however much recent evidence suggests that it enhances iron-sulfur cluster synthesis and protects iron from free radical-generating reactions. The search for frataxin function stimulated more investigations on the role of mitochondria in cellular iron homestasis. Their results suggest that these organelles may play a central role in controlling iron homeostasis, which is not surprising considering that they are the major cellular site where this metal is utilized. I propose a model, valid in yeast as well as in higher eukaryotes, in which iron trasport into mitochondria is directly coupled to its uptake at the cell membrane and iron transport out of mitochondria depends on adequate iron-sulfur cluster synthesis. Regulatory mechanisms in the cytosol would then sense a post-mitochondrial iron pool. Much circumstantial evidence from genetically manipulated yeast and from human diseases supports this model. (C) 2002 Elsevier Science (USA).
引用
收藏
页码:536 / 547
页数:12
相关论文
共 65 条
  • [1] Iron-dependent self assembly of recombinant yeast frataxin: Implications for Friedreich ataxia
    Adamec, J
    Rusnak, F
    Owen, WG
    Naylor, S
    Benson, LM
    Gacy, AM
    Isaya, G
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) : 549 - 562
  • [2] Regulation of mitochondrial iron accumulation by Yfh1p, a putative homolog of frataxin
    Babcock, M
    deSilva, D
    Oaks, R
    DavisKaplan, S
    Jiralerspong, S
    Montermini, L
    Pandolfo, M
    Kaplan, J
    [J]. SCIENCE, 1997, 276 (5319) : 1709 - 1712
  • [3] FRIEDREICH ATAXIA PHENOTYPE NOT LINKED TO CHROMOSOME-9 AND ASSOCIATED WITH SELECTIVE AUTOSOMAL RECESSIVE VITAMIN-E-DEFICIENCY IN 2 INBRED TUNISIAN FAMILIES
    BENHAMIDA, M
    BELAL, S
    SIRUGO, G
    BENHAMIDA, C
    PANAYIDES, K
    IONANNOU, P
    BECKMANN, J
    MANDEL, JL
    HENTATI, F
    KOENIG, M
    MIDDLETON, L
    [J]. NEUROLOGY, 1993, 43 (11) : 2179 - 2183
  • [4] Mitochondrial intermediate peptidase and the yeast frataxin homolog together maintain mitochondrial iron homeostasis in Saccharomyces cerevisiae
    Branda, SS
    Yang, ZY
    Chew, A
    Isaya, G
    [J]. HUMAN MOLECULAR GENETICS, 1999, 8 (06) : 1099 - 1110
  • [5] Yeast and human frataxin are processed to mature form in two sequential steps by the mitochondrial processing peptidase
    Branda, SS
    Cavadini, P
    Adamec, J
    Kalousek, F
    Taroni, F
    Isaya, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (32) : 22763 - 22769
  • [6] Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion
    Campuzano, V
    Montermini, L
    Molto, MD
    Pianese, L
    Cossee, M
    Cavalcanti, F
    Monros, E
    Rodius, F
    Duclos, F
    Monticelli, A
    Zara, F
    Canizares, J
    Koutnikova, H
    Bidichandani, SI
    Gellera, C
    Brice, A
    Trouillas, P
    DeMichele, G
    Filla, A
    DeFrutos, R
    Palau, F
    Patel, PI
    DiDonato, S
    Mandel, JL
    Cocozza, S
    Koenig, M
    Pandolfo, M
    [J]. SCIENCE, 1996, 271 (5254) : 1423 - 1427
  • [7] Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes
    Campuzano, V
    Montermini, L
    Lutz, Y
    Cova, L
    Hindelang, C
    Jiralerspong, S
    Trottier, Y
    Kish, SJ
    Faucheux, B
    Trouillas, P
    Authier, FJ
    Durr, A
    Mandel, JL
    Vescovi, A
    Pandolfo, M
    Koenig, M
    [J]. HUMAN MOLECULAR GENETICS, 1997, 6 (11) : 1771 - 1780
  • [8] Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia
    Cavadini, P
    O'Neill, HA
    Benada, O
    Isaya, G
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (03) : 217 - 227
  • [9] MAPPING OF MUTATION CAUSING FRIEDREICHS ATAXIA TO HUMAN CHROMOSOME-9
    CHAMBERLAIN, S
    SHAW, J
    ROWLAND, A
    WALLIS, J
    SOUTH, S
    NAKAMURA, Y
    VONGABAIN, A
    FARRALL, M
    WILLIAMSON, R
    [J]. NATURE, 1988, 334 (6179) : 248 - 250
  • [10] Disabled early recruitment of antioxidant defenses in Friedreich's ataxia
    Chantrel-Groussard, K
    Geromel, V
    Puccio, H
    Koenig, M
    Munnich, A
    Rötig, A
    Rustin, P
    [J]. HUMAN MOLECULAR GENETICS, 2001, 10 (19) : 2061 - 2067